Cited by 114Academic integrity and plagiarismPharmaceutical industry and healthcareMeta-analysis and systematic reviews

Multiple publication of reports of drug trials.

G�tzsche, P. C.·1989·European Journal of Clinical Pharmacology

Abstract

Fourty-four multiple publications of 31 comparative trials of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis were examined for mutual agreement. Thirty-two of the papers were published in the same language as the primary version. Important discrepancies were seen in 14 trials, involving description of the study design in two, exclusion of protocol violators in two, inconsistency in the number of effect variables in five, in the number of side-effects in five, and in the significance level in one. In three articles the conclusion became more favourable for the new drug with time. Only half of the trials had the same first author and number of authors. For six trials, multiple publication was difficult to detect. Adherence to the manuscript guidelines published by the International Committee of Medical Journal Editors should diminish the risk of inflated meta-analyses, reference lists and curricula vitae, and inexplicable discrepancies in articles based on the same data.

Integrity signals

Registry

Crossref · 10.1007/bf00558064

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
G�tzsche, P. C.
Venue
European Journal of Clinical Pharmacology
Published
1989
Volume
36
Issue
5
Pages
429-432
ISSN
  • 0031-6970 (ISSN-L)
  • 1432-1041
OpenAlex
W100934611
Cited by
113
References
13
Citations by year
2025: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 2 · 2017: 6 · 2016: 1 · 2015: 1 · 2014: 8 · 2013: 4 · 2012: 3
FWCI
1.77
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Clinical Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Safety Research › Academic integrity and plagiarism
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmaceutical industry and healthcare
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
Keywords
duplicate publication, nonsteroidal anti-inflammatory drugs, rheumatoid arthritis, comparative drug trial, meta-analysis bias, publication ethics
MeSH terms
Anti-Inflammatory Agents, Non-Steroidal, Clinical Trials as Topic, Epidemiologic Methods, Humans, MEDLARS, Publishing, Research Design, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review